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Purpose: To examine the prospective relevance of dietary sugar intake (based on dietary
data as well as urinary excretion data) in adolescent years for insulin sensitivity and
biomarkers of inflammation in young adulthood.
Methods: Overall 254 participants of the DONALD study who had at least two 3-day
weighed dietary records for calculating intakes of fructose, glucose, sucrose, total,
free, added sugars, total sugars from sugar-sweetened beverages (SSB), juice, and
sweets/sugar or at least two complete 24 h urine samples (n = 221) for calculating
sugar excretion (urinary fructose and urinary fructose+ sucrose) in adolescence (females:
9–15 years, males: 10–16 years) and a fasting blood sample in adulthood (18–36 years),
were included in multivariable linear regression analyses assessing their prospective
associations with adult homeostasis model assessment insulin sensitivity (HOMA2-%S)
and a pro-inflammatory score (based on CRP, IL-6, IL-18, leptin, chemerin, adiponectin).
Results: On the dietary intake level, no prospective associations were observed
between adolescent fructose, sucrose, glucose, added, free, total sugar, or total sugar
from SSB, juice or sweets/sugar intake and adult HOMA2-%S (p > 0.01). On the urinary
level, however, higher excreted fructose levels were associated with improved adult
HOMA2-%S (p = 0.008) among females only. No associations were observed between
dietary or urinary sugars and the adult pro-inflammatory score (p > 0.01).
Conclusion: The present study did not provide support that dietary sugar consumed in
adolescence is associated with adult insulin sensitivity. The one potential exception was
the moderate dietary consumption of fructose, which showed a beneficial association
with adult fasting insulin and insulin sensitivity.
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INTRODUCTION
It has been proposed that dietary sugar intake plays a causal
role in the development of type 2 diabetes (T2D) (1–4), yet
data on this topic are conflicting (5, 6). Due to its unregulated
uptake and hepatic metabolism, the fructose component of
high-sugar foods has been singled out as a key promotor of
adverse cardiometabolic health outcomes when consumed in
high amounts (7, 8). High intake levels of fructose administered
in such intervention and acute studies do not however represent
common intake patterns consumed habitually over time. In
addition, dietary fructose that occurs naturally in whole fruits and
vegetables provides only modest amounts of fructose combined
with phytochemicals and fiber (9, 10), therefore amounts as
well as types/sources of ingested fructose are of importance
when considering its relation to risk factors of T2D (11).
Dietary fructose elicits lower insulin secretion as compared to
dietary glucose (12–14), and there is some evidence indicating
that fructose intake/substitution can beneficially affect blood
glucose levels (15, 16). Clarifications from prospective studies
concerning the role of dietary fructose and other sugar types in
the development of insulin sensitivity are needed.
It has additionally been postulated that dietary sugar intake
leads to increased inflammatory processes in humans. While
some evidence from human intervention trials points toward
pro-inflammatory effects of sucrose and fructose vs. glucose (17,
18), our previous systematic review and meta-analysis of human
intervention trials based on limited evidence found that dietary
fructose does not contribute more to subclinical inflammation
than other dietary sugars (19). Observational studies link the
consumption of SSB to increased chronic inflammation (1, 20–
22), yet it is unclear whether a modest and habitual sugar
intake in adolescence is associated with later development of
systemic inflammation.
Adolescents generally consume more added sugars (mainly as
soft drinks) than other age groups (23, 24). Adolescence is also
characterized by substantial hormonal, metabolic, and lifestyle
changes, which is why this developmental stage is considered
a critical period for later metabolic diseases (25). Dietary
assessment methods are prone to measurement errors (26) and
sugars are among the nutrients that are frequently underreported
(27, 28) especially by adolescents who may be susceptible to
socially desired reporting. Therefore, dietary biomarkers of 24 h
urinary sucrose and urinary fructose have been introduced (29,
30), potentially allowing for greater accuracy in determining the
impact dietary sugar intake during adolescence could have on
adult metabolic health.
This analysis examined the prospective association between
the intake of dietary sugar in adolescent years and the target
outcomes of T2D risk factors (insulin sensitivity, fasting insulin,
and systemic inflammation) measured in adulthood. By using
a comprehensive approach, tests were performed on the basis
of chemical sugar types (fructose, glucose, sucrose), sugar use
(total sugar, added sugar, free sugar), and sugar sources [total
sugars from sugar-sweetened beverage (SSB), juice, sweets/sugar]
as well as urinary sugar excretion levels. This unique approach
allows for a comprehensive investigation into how various forms
of sugar measured on the self-reported dietary level as well as the
biomarker level are related to risk factors for T2D.
MATERIALS AND METHODS
Study Population
The present analysis was based on data from the DOrtmund
Nutritional and Anthropometric Longitudinally Designed Study
(DONALD Study), an open-ended and ongoing study conducted
in Dortmund, Germany. In this cohort, approximately 35–40
healthy infants are recruited per year and first examined at the
ages of 3 or 6 months. Each child returns for 3 more visits in
the first year, 2 in the second year, and then once annually until
adulthood. Between infancy and adulthood, detailed information
on diet, metabolism, growth, and development are collected.
This study began collecting this data in 1985. Components of
the annual assessment and interview include anthropometric
assessments, medical investigations, weighed 3-day dietary
records and 24 h urine samples (from age 3–4 years onwards).
Parental examinations (anthropometric measurements, lifestyle
interviews) take place every 4 years. All examinations are
performed with parental and later on, participants’ written
consent. Since 2005, participants are invited for follow-up in
adulthood including fasting blood draw. The study has been
previously described in more detail (31), and was approved by
the Ethics Committee of the University of Bonn (Germany)
according to the guidelines of the Declaration of Helsinki.
Study Sample
At the time of this analysis, 397 participants had provided
a fasting blood sample in adulthood (18–39 years) for the
measurement of type 2 diabetes risk markers. Additionally,
participants fulfilled the eligibility criteria of being singletons,
born at term (37 to <43 gestation weeks) with normal
birthweight. To estimate habitual intake of dietary sugars
during adolescence (females: 9–15 years, males: 10–16 years),
participants additionally had to have provided at least two
3-day weighed dietary records in the period of adolescence
(with >50% plausible records) (32) (n = 277) or at least two
complete 24 h urine samples in adolescent years (n = 246) for
the measurement of excreted fructose and sucrose, validated
biomarkers of sugar intake (29, 33). The plausibility of dietary
records was estimated by calculating the ratio between reported
total energy intake and estimated basal metabolic rate (estimated
according to age- and sex-specific equations of Schofield) (34). To
identify energy underreporting, pediatric cutoffs from Sichert-
Hellert et al. were used (32). Underreporters were not excluded
from the analyses, as this procedure only identifies underreported
energy intake, but no selective underreporting of food groups
or sugar intake. Instead a sensitivity analysis excluding energy
underreporters was performed. Anthropometric measurements
from adolescence and adulthood as well as information on
relevant covariates and outcome variables were required,
resulting in analysis populations of 254 participants for the
dietary intake sample and 221 participants for the HOMA-%S
biomarker sample (see Tables 1, 2) (with n= 220 providing both
dietary and biomarker data). The inflammatory score sample
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population differed slightly (n = 253 in dietary sample, and
n = 219 in the biomarker sample). Participants with fasting
glucose concentrations above the threshold (>2.5 mmol/L) for
calculating HOMA2-%S were included in the analysis (n= 254).
Dietary Assessment
Dietary intake data of the participants are collected annually by
3-day weighed dietary records under the professional direction
of a dietician. All consumed foods as well as leftovers were
weighed to the nearest gram or alternatively are recorded semi-
quantitatively if weighing was not possible. The calculation of
energy and nutrient intakes that are based on dietary records is
carried out by using the in-house food database called LEBTAB,
which is continuously updated (31). The composition of staple
foods is based on the German food composition tables BLS 3.02.
Energy and nutrient contents of commercial food products, i.e.,
processed foods and ready-to-eat-meals were estimated by recipe
simulation using labeled ingredients and nutrient contents. In
this analysis, we calculated the intake of added, free, and total
sugar, as well as fructose (defined as simple fructose + one-half
of sucrose), glucose and sucrose. Total sugar was defined as the
sum of all mono- and disaccharides in foods. Added sugar was
defined as sugars added to foods during processing or home
preparation (including honey, molasses, fruit juice concentrate,
brown sugar, corn sweetener, sucrose, lactose, glucose, high-
fructose corn syrup, and malt syrup). Because free sugar was
not included in LEBTAB, we expanded the definition from the
World Health Organization (WHO) of free sugar as suggested
by the Scientific Advisory Committee on Nutrition (SACN)
(25, 36) who states that “food subject to blending, pulping, or
macerating which breaks down the cellular structure should also
be considered as containing free sugars.” Therefore, sugars from
juices, juice spritzers and smoothies were also considered to be
free sugars in our study. Further, SSB were defined as sweetened
fruit juice drinks and nectars, soft drinks/sodas, sweetened
teas and waters, instant beverages (except dairy drinks), and
sweetened sports drinks. Juices were defined as fruits and
vegetable juices, juice spritzers, and smoothies. The sugar/sweets
food group was defined as sugars and other sweeteners (including
syrups), sweet spreads, sweets (candies) and marshmallows,
chocolate and bars, ice cream, jelly, desserts, sweet sauces, and
sweet baking ingredients. Individual dietary sugar intakes were
averaged over the three recorded days. Habitual intake was
described by calculating an individual mean from all available
records during adolescence (2–7 records per person, mean
= 6).
Anthropometric Measurements
Anthropometric measurements were taken by trained nurses
according to standard procedures. Standing height was measured
to the nearest 0.1 cm (digital stadiometer: Harpenden Ltd.,
Crymych, UK) and body weight to the nearest 0.1 kg (electronic
scale: Seca 753E, Seca Weighing and Measuring Systems,
Hamburg, Germany). From these measurements, BMI SD scores
(sex- and age-specifically standardized according to German
references) (37) and overweight during adolescence were defined
and calculated according to the International Obesity Task Force
(35).Waist circumference wasmeasured at themidpoint between
the lower rib and iliac crest to the nearest 0.1 cm. Average
coefficients of variationwere obtained from annual quality checks
for biceps, triceps, subscapular, and supra-iliacal skinfolds.
Collection and Analysis of 24h Urine
Samples
Participants are requested to collect 24 h urine annually
according to standardized instructions. The participants were
asked to void their bladders upon getting up in the morning
and this micturition was completely discarded. This sets the start
of the collection which ends with voiding the bladder in the
next morning. All micturitions from the 24 h sampling period
were collected in provided Extran-cleaned (Extran,MA03,Merck
Darmstadt, Germany) preservative-free 1 L plastic containers
and stored immediately at ≤-12◦C. After transport to the study
center the samples were stored at −22◦C until thawed for
analysis. Completeness of 24 h urine collections was determined
by measuring creatinine excretions assessed photometrically by
the kinetic Jaffé procedure on a creatinine analyzer (Beckman-
2; Beckman Instruments) (38). Participants are asked to collect a
24 h urine on the last day of the 3-day dietary record, but this is
not always the case and some persons do not provide 24 h urines
during some of the years.
Urinary fructose and sucrose excretions were measured in the
laboratory of the Department of Food and Nutritional Sciences
at the University of Reading using LC-MS and quantified using
stable-isotope labeled internal standards (13C12-sucrose and
13C6-fructose, Sigma Aldrich, Gillingham, UK). After shipping
on dry ice, urine samples were stored at −80◦C until analysis
and thawed at 4◦C. Samples were separated by HPLC and
detected by tandem mass spectrometry using a Quattro Ultima
tandem quadrupole mass spectrometer (Micromass, Manchester,
UK). The concentration range was 0.1–500 µmol/L (Fructose:
0.02–90.1 mg/L; sucrose: 0.03–171.2 mg/L). To calculate daily
excretions concentrations were converted to mg/d by using the
molar mass of fructose or sucrose and multiplied with the 24 h
urine volume (39).
Collection of Blood Parameters
Venous blood samples were drawn after an overnight fast,
centrifuged at 4◦C and stored at −80◦C. The following blood
analytes were measured at the German Diabetes Center:
plasma high-sensitivity C-reactive protein (hsCRP) using
the Roche/Hitachi Cobas c311 analyzer (Roche diagnostics,
Mannheim, Germany), plasma high-sensitivity interleukin
(IL)-6 with the Human IL-6 Quantikine HS, plasma adiponectin
with the Human Total Adiponectin/Acrp30 Quantikine ELISA
and serum leptin with the Leptin Quantikine ELISA kits all from
R&D Systems (Wiesbaden, Germany), serum IL-18 with the
Human IL-18 ELISA kit from MBL (Nagoya, Japan), and plasma
chemerin with the Human Chemerin ELISA kit from BioVendor
(Brno, Czech Republic). Plasma concentrations of insulin were
analyzed at the Laboratory for Translational Hormone Analytics
of the University of Giessen using an immunoradiometric assay
(IRMA, DRG Diagnostics, Marburg, Germany) and the updated
HOMA2-%S, a measurement of insulin sensitivity. HOMA2-%S
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TABLE 1 | Baseline characteristics of DONALD participants in adolescence (males: 10–16 years, females: 9–15 years): anthropometry, dietary and urinary data as well as
early life and socioeconomic factors.
Dietary sample Urinary sample
n M (n = 124) F (n = 130) n M (n = 109) F (n = 112)
Age (years) 254 13.0 (13.0, 13.1) 12.0 (11.9, 12.0) 221 13.0 (13.0, 13.0) 12.0 (12.0, 12.0)
Anthropometric data
BMI-SD score 254 −0.18 ± 0.77 −0.23 ± 0.92 221 −0.16 ± 0.80 −0.22 ± 0.93
BMI (kg/m2 ) 254 18.8 (17.7, 20.2) 17.8 (16.5, 20.1) 221 19.1 (17.7, 20.3) 17.9 (16.5, 20.3)
Body fat (%) 254 14.8 (11.6, 18.6) 19.6 (16.8, 24.9) 221 15.2 (11.6, 18.8) 19.6 (16.9, 25.3)
Overweight (%)a 254 22.6 22.3 221 25.7 22.3
Dietary data
Total energy (MJ/d) 254 9.0 (8.1, 10.2) 7.1 (6.6, 8.1) 221 9.0 (8.3, 10.2) 7.2 (6.6, 8.1)
Fat (%E) 254 35.3 ± 3.8 36.1 ± 3.5 221 34.9 ± 3.4 36.2 ± 3.5
Protein (%E) 254 13.2 ± 1.3 12.9 ± 1.7 221 13.2 ± 1.3 12.9 ± 1.7
Fiber (g/MJ) 254 2.4 (2.1, 2.7) 2.5 (2.2, 2.8) 221 2.4 (2.2, 2.8) 2.5 (2.1, 2.8)
Carbohydrate (%E) 254 51.3 ± 3.8 51.1 ± 4.3 221 51.5 ± 3.9 51.1 ± 4.4
Total sugar (%E) 254 26.8 ± 5.0 27.1 ± 5.0 221 27.0 ± 5.1 27.0 ± 4.9
Added sugar (%E) 254 14.3 ± 4.3 14.1 ± 4.7 221 14.2 ± 4.4 14.1 ± 4.7
Free sugar (%E) 254 18.2 ± 4.6 17.7 ± 5.0 221 18.4 ± 4.6 17.6 ± 5.0
Sucrose (%E) 254 14.4 ± 3.8 14.6 ± 3.9 221 14.4 ± 3.8 14.5 ± 3.8
Fructose (%E) 254 11.3 ± 2.6 11.4 ± 2.5 221 11.4 ± 2.6 11.3 ± 2.4
Glucose (%E) 254 11.5 ± 2.5 11.8 ± 2.7 221 11.4 ± 2.5 11.8 ± 2.7
Sources of total sugar
Juice (%E) 254 4.0 ± 3.5 3.6 ± 2.9 221 4.3 ± 3.6 3.5 ± 2.9
SSB (%E) 254 4.5 ± 3.9 3.9 ± 3.7 221 4.4 ± 3.8 4.0 ± 3.5
Fruits and vegetables (%E) 254 3.2 ± 1.8 4.3 ± 1.9 221 3.2 ± 1.8 4.3 ± 1.9
Sweet breads/cakes (%E) 254 1.2 ± 0.8 1.4 ± 0.8 221 1.3 ± 0.8 1.4 ± 0.9
Sweets/sugar (%E) 254 6.2 ± 2.5 7.0 ± 2.7 221 6.0 ± 2.4 6.9 ± 2.6
Sweetened cereals (%E) 254 1.0 ± 0.9 0.7 ± 0.6 221 1.1 ± 1.1 0.7 ± 0.7
Dairy sugars (%E) 254 5.3 ± 2.5 4.8 ± 2.2 221 5.5 ± 1.5 4.8 ± 1.0
Urinary data
Urinary fructose (mg/d) 221 22.3 (14.5, 32.3) 21.2 (13.4, 32.3)
Fructose+sucrose (mg/d) 221 52.7 (37.2, 79.0) 46.3 (34.4, 68.2)
Creatinine (mmol/L) 221 9.5 (6.7, 11.5) 7.6 (6.0, 10.0)
Urea (mmol/L) 221 323 (255, 416) 272 (216, 349)
Urine Volume (L/d) 221 0.9 (0.7, 1.3) 1.0 (0.7, 1.2)
Early life/socioeconomic data
Birth weight (g) 254 3500 (3150, 3845) 3405 (3100, 3700) 221 3550 (3180, 3850) 3400 (3100, 3655)
Gestational age (week) 254 40 (39, 41) 39 (38, 41) 221 40 (39, 41) 40 (39, 41)
Gestational weight gain (kg) 254 12.0 (9.5, 14.5) 12.0 (9.0, 15.0) 221 12 (10, 15) 12 (10, 15)
Maternal age at birth (year) 254 30.7 (28.3, 33.7) 30.0 (27.8, 32.7) 221 30.8 (28.3, 33.6) 29.7 (27.7, 32.6)
Full breastfeeding >2 weeks (%) 254 74 73 221 75 76
Paternal education ≥12 y (%) 254 65 57 221 64 57
Any smokers in household (%) 254 27 37 221 28 37
Values are means ± SD, medians (25th, 75th percentile) or relative frequencies. BMI, body mass index; %E = percentage of total energy intake; DONALD Dortmund Nutritional and
Anthropometric Longitudinally Designed; Pubertal age: mean age at pubertal data collection (mean of multiple time points). aDefined according to age- and sex-specific cut points of
the International Obesity Task Force (1, 35); Dietary fructose intake is defined to be free fructose plus 50% of sucrose. Dietary glucose intake is defined to be free glucose plus 50%
of sucrose.
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TABLE 2 | Follow-up data on DONALD participants in early adulthood (18–36 years): anthropometric and lifestyle, dietary and blood data.
Dietary sample Urinary sample
n M (n = 124) F (n = 130) n M (n = 109) F (n = 112)
Adult age (years) 254 20.5 (18.1, 23.0) 21.3 (18.1, 24.2) 221 19.0 (18.1, 23.0) 21.3 (18.1, 24.2)
Anthropometric data
BMI (kg/m2 ) 253 22.7 (21.1, 25.6) 21.9 (20.5, 24.1) 221 22.7 (21.0, 25.6) 21.9 (20.5, 24.1)
Body fat (%) 253 17.2 (13.4, 22.2) 30.4 (27.2, 33.3) 221 17.4 (13.3, 21.9) 30.5 (27.0, 33.2)
Current smoking (%) 235 36.8 32.7 202 32.3 28.4
Physical activity levela 252 1.2 (1.1, 1.4) 1.2 (1.1, 1.2) 220 1.2 (1.1, 1.4) 1.2 (1.1, 1.3)
Alcohol intake (g/d) 228 1.3 (0.01, 12.5) 0.2 (0.0, 2.9) 203 1.4 (0.1, 11.6) 0.3 (0.1, 3.0)
Dietary data
Total energy (MJ/d) 229 10.6 (9.3, 12.5) 7.9 (6.6, 8.8) 203 10.5 (9.3, 12.4) 8.0 (6.7, 9.0)
Added sugar (%E) 229 13.3 ± 6.8 12.7 ± 7.4 203 13.4 ± 7.4 12.8 ± 7.2
Protein (%E) 229 14.3 ± 3.8 13.5 ± 2.6 203 14.5 ± 3.9 13.4 ± 2.2
Carbohydrates (%E) 229 48.6 ± 6.7 51.0 ± 6.4 203 48.8 ± 7.0 51.0 ± 6.1
Fat (%E) 229 36.0 ± 5.0 34.6 ± 4.7 203 36.3 ± 5.1 34.9 ± 5.9
Fiber (g/MJ) 229 2.4 (2.0, 2.9) 2.2 (1.9, 2.7) 203 2.2 (1.9, 2.7) 2.5 (2.2, 3.0)
Blood data
Fasting blood glucose (mmol/L) 254 5.5 (5.1, 5.8) 5.2 (4.9, 5.4) 221 5.5 (5.1, 5.8) 5.2 (4.9, 5.4)
Insulin (pmol/L) 254 64.1 (52.7, 85.5) 71.4 (55.4, 88.2) 221 64.0 (52.1, 85.8) 72.9 (57.3, 89.4)
HOMA2-%S 254 81.7 (61.7, 100.4) 73.5 (960.5, 94.2) 221 81.8 (60.9, 100.6) 73.0 (60.5, 93.9)
hsCRP (mg/L) 250 0.5 (0.3, 1.1) 1.2 (0.6, 2.6) 217 0.5 (0.3, 1.3) 1.3 (0.6, 2.7)
IL-6 (pg/mL) 250 0.7 (0.5, 1.0) 0.7 (0.5, 1.0) 217 0.7 (0.5, 1.0) 0.7 (0.5, 1.0)
IL-18 (pg/mL) 250 252 (204, 308) 246 (209, 306) 217 249 (204, 303) 247 (207, 306)
Chemerin (ng/mL) 250 141 (123, 160) 165 (150, 184) 217 141 (123, 159) 165 (150, 183)
Leptin (ng/mL) 250 2.4 (1.2, 5.0) 11.6 (7.8, 18.0) 217 2.3 (1.1, 5.1) 11.7 (7.8, 18.2)
Adiponectin (µg/mL) 250 6.2 (4.5, 9.2) 8.7 (6.5, 12.5) 217 6.4 (4.7, 9.2) 8.7 (6.4, 12.9)
Inflammatory score 250 −0.13 (−0.37, 0.28) −0.07 (−0.38, 0.37) 217 −0.15 (−0.37, 0.26) −0.06 (−0.38, 0.38)
Values are means ± SD, medians (25th, 75th percentile) or relative frequencies. BMI, body mass index; %E = percentage of total energy intake; DONALD Dortmund Nutritional
and Anthropometric Longitudinally Designed; HOMA2-%S updated homeostasis model assessment of insulin sensitivity, hsCRP high-sensitivity C-reactive protein. aBased on energy
expenditure levels.
was calculated by using the HOMA2 calculator (40). It is a
reciprocal of HOMA2-IR (insulin resistance) and is a function of
glucose metabolism driven by the action of insulin.
To examine the association of dietary sugar on chronic
low-grade inflammation in the DONALD Study, the pro-
inflammatory markers CRP, IL-6, IL-18, chemerin, and leptin
and the anti-inflammatory adipose tissue hormone adiponectin
were considered. These biomarkers of subclinical inflammation
were selected because they are the most commonly measured
inflammation-related biomarkers in clinical and epidemiologic
studies with established associations with cardiometabolic
diseases (41–45).
A pro-inflammatory score, assumed to be more predictive
of inflammation than single markers (43), was obtained as
follows: (1) standardization of each inflammatory parameter
(hsCRP, IL-6, IL-18, chemerin, leptin, adiponectin) by sex (mean
= 0, SD = 1), (2) assignment of a minus sign to the anti-
inflammatory parameter adiponectin to align its impact with the
pro-inflammatory parameters, and (3) averaging all. This index
has been used in previous publications (46, 47).
Assessment of Further Covariates
Additional covariates were assessed either at the child’s admission
into the study or at follow-up visits. Characteristics of birth
were retrieved from the “Mutterpass” (a German standardized
pregnancy and birth document). Child’s parents were interviewed
in order to collect familial information, disease history,
socioeconomic status and other anthropometrical and medical
examinations. Smoking status, high paternal educational status
(≥12 years of schooling), and physical activity of the participants
was also assessed by questionnaires.
Statistical Analysis
Characteristics of the study population are presented as mean
± SD or median (25th, 75th percentile) for continuous variables
and as absolute (relative) frequencies for categorical variables (see
Tables 1, 2).
To achieve normal distribution in outcome variables we
used loge or square root transformations. Before calculating
the individual means from available records or urines during
adolescence, dietary variables were energy-adjusted by the
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residual method and standardized by age group and sex to
account for age- and sex-dependent intake differences. Urinary
excretion variables were also standardized by age group and sex
but were not energy-adjusted so as to keep the dietary and urinary
analyses separate, thereby avoiding the mixing of potential errors
from dietary record assessments with biomarker measurements,
as they are differently biased.
Prospective associations between dietary sugar intake (total
sugar, added sugar, free sugar, sucrose, fructose, glucose, total
sugar from SSB, juice, and sweets/sugar) or sugar excretion
(fructose excretion, sucrose excretion, sum of both) during
adolescence and risk markers of type 2 diabetes or inflammation
in early adulthood were analyzed by multivariable linear
regression models, using the transformed variables. Formal
interaction analyses indicated a trend in sex-interactions
for insulin sensitivity and excreted fructose biomarker level
(Pinteraction = 0.06); therefore, sex-stratified analyses were
performed for all outcomes on both the dietary and the
biomarker level in order to allow comparability.
Initial regression models (model A) included the predictors
sugar intake (total, free, added, sucrose, fructose, or glucose)
or urinary biomarkers (fructose or sum of both) as well
as age at time of blood draw. Adjusted models (model
B) were constructed by individual examination of potential
influencing covariates and hierarchical inclusion (16) of those
which substantially modified the predictor–outcome associations
(≥10%) or significantly predicted the outcome. Potential
confounding covariates considered in the hierarchical approach
were (1) early life factors [birth weight (g), gestational age (week),
maternal age at birth (year), full breastfeeding ≥ 4 months
(yes/no), and gestational weight gain (kg)], (2) socioeconomic
factors and parental health status [smokers in the household
(yes/ no), paternal school education ≥12 years (yes/no), parental
overweight (BMI ≥25 kg/m2 yes/no) and parental history of
diabetes (yes/no)], (3) predictor-specific adolescent data [BMI,
BMI-SD score, percent body fat, age, energy- and fructose-
adjusted flavonoid intake and glycemic index, and energy-
adjusted fiber intake in models with the dietary predictors
sugar intake]. For biomarker analyses, urinary variables [24 h-
creatinine excretion (mmol/d), 24 h-urea excretion (mmol/d),
urine volume (L/d), excreted hippuric acid (mmol/d)] were also
considered. In conditional models (model C) we additionally
included adult body fat (%) to examine whether observed
associations were independent of adult body composition. To
retain comparability of results, models were adjusted identically
for closely related outcomes (parameters of insulin sensitivity
(fasting insulin, HOMA2-%S) and separately for the pro-
inflammatory score) and the building of the models was done for
the primary exposures, i.e., dietary fructose or excreted fructose
and then used for analyses of the secondary exposures, i.e.,
free sugar, total sugar, etc. Results from regression analyses are
presented as adjusted least-square means (95% CI) by tertiles
of the respective predictor with p-values from models with the
predictors as continuous variables.
Our main analyses did not include nutritional factors
that provide energy so as to avoid presenting estimates that
partially reflect the substitution of specific sugars for other
macronutrients. Additional models were run that explicitly assess
the effect of a substitution of various dietary sugar fractions for
non-sugar carbohydrates, i.e., total carbohydrates (g) minus all
mono- and disaccharides (g). To simulate substitution effects,
total energy and the energy-bearing nutrients to be held constant
(fats, plant/animal protein and sugar-containing carbohydrates)
were included in the models (48). All results from substitution
analyses are presented in Supplementary Material for fully
adjusted models.
As mentioned in the methods section, adolescents are
susceptible to underreporting energy intake, therefore records
were checked for energy underreporting. The number of records
in which energy levels were underreported was 209 (12.6%).
These were collected from 109 participants, and were excluded
for sensitivity analyses; i.e., sensitivity analyses were based on
1,446 records from 277 participants.
Additional sensitivity analyses in subsamples of participants
who had provided the following data were performed
in dietary/urinary models: (a) levels of adult physical
activity (low/medium/high; n = 252/218), (b) adult alcohol
consumption (g/d; n = 229/203), (c) adult smoking (no, yes,
earlier; n= 235/202).
The SAS statistical software package version 9.2 (SAS Institute
Inc., Cary, NC) was used for all statistical analyses. To account for
potential multiple testing, p < 0.01 were considered to indicate
statistical significance, p < 0.05 were considered to indicate a
trend.
RESULTS
Characteristics of the participants at baseline and at follow-up
are presented in Tables 1, 2, respectively. The median follow-up
times between the mean age during adolescence and adulthood
were 9.0 years in the dietary sample and 8.6 years in the urinary
sample. Participants were characterized by an above-average
socioeconomic status as measured by the high percentage of
participants’ fathers with an education level >12 years. Tertiles
of fructose, sucrose, glucose, total sugar, free sugar and added
sugar intakes as well as the urinary sugars are shown in Tables 3–
5. For results on sources of sugar (total sugars from SSB, juice and
sweets/sugar; see Supplementary Table 4).
Adolescent Sugar Intake and Adult Insulin
and Insulin Sensitivity
Intakes of dietary fructose, glucose or sucrose in adolescence were
not independently associated with adult HOMA2-S% or insulin
levels (all p> 0.01,Table 3). Similarly, there were no independent
associations between total, free, or added sugar as well as total
sugar intakes from SSB, juice, and sweets/sugar in adolescence
and adult HOMA2-S% or insulin levels (all p > 0.01, Table 4).
On the biomarker level, a higher adolescent excretion of
urinary fructose was associated with lower fasting insulin and
higher adult insulin sensitivity among females (p = 0.007 and
p = 0.008, respectively, Table 5, model C; Figure 1). Among
males, sugar excretion levels were not associated with adult
insulin sensitivity markers.


























TABLE 3 | Sex-stratified prospective associations of total dietary fructose, sucrose, and glucose intake during adolescence with markers of insulin sensitivity in early adulthood [n = 254: (124 males, 130 females)].
Tertiles of fructose intake Tertiles of glucose intake Tertiles of sucrose intake
Females Low (T1) Moderate
(T2)
High (T3) Ptrend Low (T1) Moderate
(T2)





36 (32; 43) 47
(44; 53)
63 (56; 70) 39 (32; 43) 50
(43; 58)




Model A 79.3 (69.5; 89.2) 80.3
(70.1; 90.5)
72.6 (62.7; 82.5) 0.03 85.5 (75.9; 95.2) 78.0
(67.9; 88.1)
68.7 (59.0; 78.3) 0.05 82.8 (73.0; 92.5) 80.1
(70.3; 89.9)
68.8 (58.7; 78.8) 0.03
Model B 76.3 (66.7; 85.9) 79.9
(70.0; 89.8)
72.4 (62.8; 82.0) 0.11 81.5 (71.4; 91.6) 76.8
(66.6; 87.0)
70.8 (61.0; 80.6) 0.25 77.9 (67.5; 88.2) 79.0
(69.3; 88.7)
71.5 (61.4; 81.6) 0.20
Model C
(conditional)
76.6 (66.9; 86.3) 79.2
(69.2; 89.2)
72.7 (63.0; 82.4) 0.17 80.9 (70.9; 90.9) 77.5
(67.4; 87.6)
70.7 (61.0; 80.4) 0.36 78.7 (68.5; 89.0) 79.0
(69.5; 88.6)
70.7 (60.6; 80.7) 0.20
HOMA2-%S
Model A 71.8 (65.0; 79.5) 71.7
(64.6; 79.6)
79.1 (71.5; 87.6) 0.04 67.8 (61.4; 74.9) 73.7
(66.5; 81.8)
81.6 (73.9; 90.1) 0.06 68.8 (62.3; 76.0) 73.7
(66.7; 81.5)
80.9 (73.0; 89.7) 0.03
Model B 74.2 (67.3; 81.8) 72.5
(65.6; 80.2)
78.9 (71.5; 87.0) 0.13 68.8 (62.3; 76.0) 73.7
(66.7; 81.5)
81.0 (73.0; 89.7) 0.28 72.7 (65.4; 80.7) 74.6
(67.6; 82.2)
78.3 (70.7; 86.8) 0.25
Model C
(conditional)
78.1 (69.1; 88.3) 76.2
(67.8; 85.6)
86.6 (77.1; 97.2) 0.20 71.5 (64.6; 79.1) 74.1
(66.9; 82.1)
79.6 (72.2; 87.8) 0.39 72.0 (64.9; 79.8) 74.5
(67.7; 82.1)
79.1 (71.4; 87.5) 0.24
Males Low (T1) Moderate
(T2)
High (T3) Ptrend Low (T1) Moderate
(T2)
High (T3) Ptrend Low (T1) Moderate
(T2)
High (T3) Ptrend
Dietary sugar (g/d)a 47 (41; 50) 62
(52; 68)
79 (71; 89) 48 (38; 55) 61
(55; 72)




Model A 70.9 (60.9; 80.9) 78.3
(68.1; 88.4)
63.7 (53.8; 73.6) 0.95 65.4 (55.1; 76.9) 79.9
(68.8; 91.1)
71.8 (60.8; 82.8) 0.99 73.0 (62.5; 83.6) 72.8
(62.9; 82.6)
66.8 (56.6; 77.0) 0.41
Model B 71.0 (60.1; 81.9) 79.1
(68.7; 89.5)
64.2 (53.9; 74.5) 0.99 68.6 (57.5; 79.7) 72.5
(62.1; 83.0)
72.7 (62.5; 82.9) 0.87 73.8 (62.2; 85.5) 73.5
(63.4; 83.5)
67.3 (56.7; 77.9) 0.79
Model C
(conditional)
71.6 (60.1; 82.0) 78.7
(68.3; 89.1)
64.7 (54.5; 75.0) 0.96 68.3 (57.2; 79.4) 73.3
(62.8; 83.9)
72.2 (61.9; 82.4) 0.90 73.4 (61.7; 85.1) 74.3
(64.2; 84.4)
66.7 (56.1; 77.3) 0.75
HOMA2-%S
Model A 77.8 (69.4; 87.1) 76.9
(68.5; 86.3)
86.5 (77.3; 96.8) 0.90 79.9 (71.0; 90.0) 84.9
(75.8; 95.0)
76.6 (68.5; 85.6) 0.98 75.2 (66.8; 84.7) 80.9
(72.4; 90.4)
84.8 (75.6; 95.1) 0.40
Model B 78.1 (69.0; 88.3) 76.7
(68.2; 86.2)
86.0 (76.5; 96.6) 0.95 75.2 (66.8; 84.7) 80.9
(72.4; 90.4)
84.8 (75.6; 95.1) 0.89 75.0 (65.8; 85.4) 80.2
(71.7; 89.8)
84.7 (75.3; 95.4) 0.76
Model C
(conditional)
74.4 (67.6; 82.0) 72.0
(65.1; 79.5)
79.1 (71.9; 87.2) 0.89 80.8 (71.4; 91.5) 83.4
(74.2; 93.8)
77.1 (68.8; 86.4) 0.92 75.4 (66.3; 85.9) 79.3
(70.8; 88.7)
85.5 (76.0; 96.2) 0.72
Values are adjusted least-squares means (95% CIs) unless otherwise indicated. Linear trends (Ptrend ) were obtained in sex-stratified linear regression models with the transformed and energy-adjusted predictors dietary fructose, sucrose,
and glucose adolescent intakes as continuous variables. Model A adjusted for adult age at time of blood draw. Model B, with outcomes HOMA2-%S and fasting insulin, additionally adjusted for paternal education, birth weight, gestational
weight gain, smoking in the household, parental overweight and pubertal percent body fat. Model C, the conditional model, additionally adjusted for adult percent body fat for all predictors and outcomes. Transformations of variables
for analysis: loge for HOMA2-%S, fasting insulin, dietary sucrose and glucose; square root for dietary fructose. HOMA2-%S: updated homeostasis model assessment of insulin sensitivity.
aValues are unadjusted medians (25th, 75th







































































TABLE 4 | Sex-stratified prospective associations of total dietary sugar, added sugar, and free sugar intake during adolescence with markers of insulin sensitivity in early adulthood [n = 254: (124 males, 130 females)].
Tertiles of total sugar intake Tertiles of added sugar intake Tertiles of free sugar intake
Females Low (T1) Moderate
(T2)
High (T3) Ptrend Low (T1) Moderate
(T2)





88 (79; 105) 113
(103; 129)
143 (128; 160) 39 (33; 47) 61
(50; 73)




Model A 81.3 (71.5; 91.0) 80.2
(70.1; 90.3)
70.7 (60.9; 80.6) 0.05 84.0 (74.2; 93.7) 76.9
(66.9; 86.8)
71.0 (61.0; 81.0) 0.24 81.1 (71.3; 90.9) 78.8
(68.6; 88.9)
72.3 (62.4; 82.2) 0.28
Model B 77.7 (67.6; 87.7) 78.8
(68.7; 88.9)
72.2 (62.4; 81.9) 0.23 79.2 (68.8; 89.6) 75.8
(66.0; 85.7)
73.5 (63.3; 83.6) 0.79 76.7 (66.7; 86.6) 78.7
(68.6; 88.7)
73.2 (63.4; 83.0) 0.51
Model C
(conditional)
76.6 (66.6; 86.6) 80.5
(70.3; 90.6)
71.7 (62.0; 81.4) 0.28 79.6 (69.3; 89.9) 76.3
(66.6; 86.1)
72.6 (62.5; 82.7) 0.66 76.8 (67.0; 86.7) 79.1
(69.1; 89.0)
72.7 (63.0; 82.4) 0.54
HOMA2-%S
Model A 71.1 (64.4; 78.6) 71.3
(64.3; 79.1)
80.5 (72.7; 89.0) 0.06 68.5 (62.0; 75.7) 75.7
(63.3; 83.9)
79.0 (71.3; 87.5) 0.28 70.8 (64.1; 78.3) 72.5
(65.4; 80.5)
79.4 (71.7; 87.9) 0.32
Model B 74.2 (67.0; 82.1) 72.3
(65.3; 80.1)
78.9 (71.5; 87.1) 0.27 72.5 (65.2; 80.5) 76.4
(69.2; 84.4)
76.6 (69.1; 84.9) 0.87 74.6 (67.5; 82.5) 72.3
(65.4; 80.0)
78.5 (71.1; 86.6) 0.57
Model C
(conditional)
75.0 (67.9; 83.0) 71.0
(64.1; 78.6)
79.4 (72.0; 87.5) 0.33 72.1 (65.0; 80.1) 76.0
(68.9; 83.9)
77.3 (69.9; 85.6) 0.73 74.5 (67.5; 82.2) 72.0
(65.2; 79.6)
78.9 (71.6; 87.0) 0.61
Males Low (T1) Moderate
(T2)
High (T3) Ptrend Low (T1) Moderate
(T2)
High (T3) Ptrend Low (T1) Moderate
(T2)
High (T3) Ptrend
Dietary sugar (g/d)a 110 (95, 128) 148
(135, 172)
173 (150, 200) 51 (42, 68) 73
(67, 89)




Model A 70.3 (60.0; 80.6) 74.5
(64.4; 84.5)
67.7 (57.5; 77.9) 0.91 65.9 (55.4; 76.4) 76.9
(67.2; 86.6)
68.9 (58.9; 79.0) 0.92 68.4 (57.8; 78.9) 76.2
(66.4; 86.1)
67.6 (57.6; 77.6) 0.28
Model B 70.5 (59.4; 81.5) 75.6
(65.3; 86.0)
67.9 (57.4; 78.4) 0.86 66.6 (55.6; 77.6) 76.6
(66.6; 86.6)
70.1 (59.7; 80.5) 0.72 69.0 (57.5; 80.4) 76.4
(66.3; 86.6)
68.6 (58.3; 78.9) 0.78
Model C
(conditional)
70.5 (59.5; 81.5) 76.0
(65.7; 86.3)
67.5 (57.0; 78.0) 0.87 66.6 (55.6; 77.6) 76.8
(66.8; 86.8)
69.8 (59.4; 80.2) 0.79 68.5 (57.0; 79.9) 77.2
(67.0; 87.4)
68.1 (57.9; 78.4) 0.89
HOMA2-%S
Model A 78.8 (70.2; 88.5) 79.5
(71.0; 89.1)
82.8 (73.8; 92.9) 0.85 84.0 (74.3; 94.5) 76.5
(68.5; 85.4)
81.4 (72.6; 91.2) 0.97 80.4 (71.4; 90.6) 77.8
(69.6; 87.0)
83.0 (74.1; 93.0) 0.93
Model B 79.2 (70.0; 89.7) 78.6
(70.0; 88.3)
83.0 (73.7; 93.3) 0.93 83.9 (74.1; 95.0) 77.2
(68.8; 86.4)
80.4 (71.5; 90.4) 0.69 80.4 (70.7; 91.5) 78.1
(69.7; 87.6)
82.1 (73.1; 82.2) 0.79
Model C
(conditional)
79.2 (70.0; 89.7) 78.2
(69.6; 87.8)
83.5 (74.2; 93.9) 0.95 83.9 (74.2; 95.0) 77.0
(68.8; 86.1)
80.8 (71.9; 90.8) 0.77 81.0 (71.3; 92.1) 77.2
(68.9; 86.6)
82.7 (73.7; 92.8) 0.89
Values are adjusted least-squares means (95% CIs) unless otherwise indicated. Linear trends (Ptrend ) were obtained in sex-stratified linear regression models with the transformed and energy-adjusted predictors dietary fructose, sucrose,
and glucose adolescent intakes as continuous variables. Model A adjusted for adult age at time of blood draw. Model B, with both outcomes HOMA2-%S and fasting insulin additionally adjusted for paternal education, birth weight,
gestational weight gain, smoking in the household, parental overweight and pubertal percent body fat. Model C, the conditional model, additionally adjusted for adult percent body fat for all predictors and outcomes. Transformations
of variables for analysis: loge for HOMA2-%S, fasting insulin, total sugar intake; square root for added sugar and free sugar intakes. HOMA2-%S: updated homeostasis model assessment of insulin sensitivity.
aValues are unadjusted
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TABLE 5 | Sex-stratified prospective associations of urinary fructose, urinary sucrose, and the sum of urinary fructose and sucrose excretion during adolescence with
markers of insulin sensitivity in early adulthood [(n = 221: (109 males, 112 females))].
Tertiles of urinary fructose Tertiles of urinary fructose + sucrose
Females Low (T1) Moderate (T2) High (T3) Ptrend Low (T1) Moderate (T2) High (T3) Ptrend
Urinary sugar (mg/d)a 10.1 (7.9, 13.3) 21.2
(19.0, 24.5)




Model A 80.6 (70.7; 90.4) 82.2
(72.4; 91.9)
69.4 (59.5; 79.2) 0.013 78.2 (68.2; 88.2) 78.0
(67.9; 88.2)
76.1 (66.3; 85.9) 0.29
Model B 79.7 (70.0; 89.4) 81.9
(72.3; 91.4)
67.8 (58.1; 77.5) 0.011 76.9 (67.0; 86.9) 77.0
(67.1; 86.9)
75.7 (66.1; 85.3) 0.24
Model C
(conditional)
80.4 (70.9; 89.8) 80.6
(71.3; 90.0)
68.6 (59.2; 78.1) 0.007 76.2 (66.6; 85.9) 79.0
(69.3; 88.8)
74.8 (65.5; 84.2) 0.18
HOMA2-%S
Model A 69.3 (62.5; 76.9) 70.5
(63.6; 78.1)
83.0 (74.8; 92.1) 0.015 71.7 (64.4; 79.7) 73.9
(66.3; 82.4)
76.3 (68.8; 84.7) 0.31
Model B 70.0 (63.3; 77.4) 70.6
(64.0; 78.0)
84.7 (76.6; 93.6) 0.013 72.5 (65.4; 80.5) 74.9
(67.5; 83.1)
76.7 (69.3; 84.8) 0.25
Model C
(conditional)
69.5 (63.0; 76.7) 71.4
(64.8; 78.7)
84.0 (76.2; 92.7) 0.008 73.0 (66.0; 80.9) 73.5
(66.3; 81.5)
77.3 (70.0; 85.3) 0.19
Males Low (T1) Moderate
(T2)
High (T3) Ptrend Low (T1) Moderate
(T2)
High (T3) Ptrend
Urinary sugar (mg/d)a 12.5 (9.9, 14.2) 22.3
(18.3, 23.2)




Model A 72.5 (59.8; 85.3) 79.9
(67.6; 92.1)
65.2 (52.7; 77.8) 0.20 76.2 (63.6; 88.9) 74.6
(62.1; 87.1)
67.2 (54.4; 79.9) 0.53
Model B 72.2 (59.4; 85.0) 80.7
(68.3; 93.1)
65.6 (53.2; 78.1) 0.23 75.2 (62.3; 88.0) 76.0
(63.4; 88.6)
67.3 (54.7; 80.0) 0.74
Model C
(conditional)
73.6 (60.6; 86.7) 79.7
(67.1; 92.2)
65.0 (52.5; 77.5) 0.10 76.6 (63.7; 89.5) 77.1
(63.6; 88.7)
65.5 (52.6; 78.3) 0.18
HOMA2-%S
Model A 79.0 (69.1; 90.2) 74.6
(65.7; 84.8)
85.6 (75.1; 97.6) 0.20 76.4 (66.9; 87.1) 78.7
(69.1; 89.6)
83.7 (73.3; 95.6) 0.50
Model B 79.4 (69.5; 90.8) 74.1
(65.1; 84.4)
85.4 (75.0; 97.2) 0.23 77.4 (67.7; 88.4) 77.6
(68.1; 88.5)
83.7 (67.7; 88.4) 0.71
Model C
(conditional)
77.2 (67.5; 88.3) 75.6
(66.5; 86.0)
86.4 (76.0; 98.2) 0.10 75.5 (66.1; 86.1) 77.5
(68.2; 88.1)
86.4 (75.8; 98.5) 0.29
Values are adjusted least-squares means (95% CIs) unless otherwise indicated. Linear trends (Ptrend ) were obtained in sex-stratified linear regression models with the predictors urinary
fructose, urinary sucrose, and sum of urinary fructose and sucrose as continuous variables. Model A adjusted for adult age at time of blood draw. Model B, with outcomes HOMA2-%S
and fasting insulin, additionally adjusted for paternal education, pubertal percent body fat and gestational weight gain. The conditional Model C additionally adjusted for adult percent
body fat for all predictors and outcomes. Transformations of variables for analysis: loge for HOMA2-%S, fasting insulin; square root for excreted urinary fructose; loge(loge ) for sum of
excreted fructose and sucrose. HOMA2-%S: updated homeostasis model assessment of insulin sensitivity. aValues are unadjusted medians (25th, 75th percentile). Bold values indicate
significant findings (p < 0.01) or trends (p< 0.05).
Adolescent Sugar Intake and Adult
Systemic Inflammation
Intakes of glucose, fructose, sucrose, total sugar, free sugar
or added sugar as well as total sugar intakes from SSB,
juice and sweets/sugar were not independently associated
with the pro-inflammatory score in adulthood (all p >
0.01; see Supplementary Tables 1, 2, 4). Similarly, sugar
excretion levels during adolescence were not associated with
the pro-inflammatory score in adulthood (all p > 0.01,
Supplementary Table 3).
Sensitivity Analyses
All sensitivity analyses yielded similar results as the main
investigation, i.e., did not significantly change any observed
associations. The results from the substitution analyses
indicate that the replacement of each sugar type for
non-sugar carbohydrates did not result in any significant
associations for the outcomes of pro-inflammatory score (see
Supplementary Table 5), fasting insulin and insulin sensitivity
(see Supplementary Table 6).
DISCUSSION
In the present longitudinal study, a unique database compiled
from self-reported sugar intake data and urinary fructose and
sucrose excretion as dietary sugar intake biomarkers was used
to investigate the role of dietary sugars in adolescence for adult
risk markers of T2D. The main finding suggests that dietary
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FIGURE 1 | Serum levels of fasting insulin and insulin sensitivity (HOMA2-%S) in early adulthood by tertiles of excreted urinary fructose among females and males in
adolescence. Data are generic means and 95% CI adjusted for age at time of blood draw, paternal education, pubertal percent body fat, gestational weight gain and
adult percent body fat.
sugar was not consistently related to adult T2D risk factors.
The only exception was the urinary fructose biomarker, which
was beneficially associated with HOMA2-S% and fasting insulin
levels among females only. No other associations were found
between the various dietary/urinary sugars and insulin sensitivity
or chronic inflammation.
Other reported observational evidence was consistent
with our prospective association between fructose intake and
improved HOMA2-S% and insulin levels (49, 50), and further
sources reporting on large cohorts found no association between
fructose-containing sugars and incident T2D (51–53) contrary
to the popular opinion that sugar intake increases risk for T2D.
A meta-analysis of 15 prospective cohort studies reported no
association of total sugar and fructose intake with T2D, and a
higher sucrose consumption was associated with a decreased
risk in T2D (54). The main predictors in these studies reported
findings that emerged when investigating chemical sugar types,
as was similarly done in our study. The observational studies
referenced here similarly adjusted for anthropometric measures
and energy intake as was done in our study but did not measure
sugar intake by means of urinary biomarkers. When consumed
in high amounts, dietary fructose has been associated in cohort
studies with increased risk of T2D (55, 56). Inconsistent findings
related to sugar intake and diabetes risk may result from varying
levels of sugar intake and the possibility that different sugars
elicit different metabolic effects (57). Our results pertaining
to biomarkers of inflammation indicated no relationship with
sugar intake. Only when analyzing sugar as a source of SSB was
it associated with an increased pro-inflammatory score among
females (Ptrend < 0.05). This is consistent with observational
evidence that consistently links SSB intake with increased
chronic inflammation (more specifically CRP) (1, 20–22).
There is an array of categories and uses by which dietary sugar
is defined and tested for in nutritional research. Broken down on
a chemical level, the monosaccharides fructose and glucose and
the disaccharide sucrose are assumed to have unique metabolic
effects on outcomes of health. Other sugar categories of total,
added, or free sugars may each be of physiological relevance,
i.e., causing varying effects on absorption, satiety, caloric
compensation, or insulin response. Since dietary assessment
methods are prone to measurement errors (26) and sugars are
among the nutrients that are frequently underreported (27, 28),
objective dietary biomarkers of 24 h urinary sucrose and urinary
fructose have been introduced (29, 30). The inconsistencies often
found in epidemiological studies that investigate links between
sugars and chronic disease may in part be due to the ambiguity
of not only the definition and type of sugar but the sugar source
as well (9–11). When the main sources of dietary fructose are
fruits and vegetables in their whole form and not as juice,
prospective studies have shown inverse associations with the
risk of incident diabetes (58, 59). This may be related to factors
specifically associated with fruit and vegetable intake, such as
particular micronutrients or dietary patterns that are related to
a lower risk of diabetes. Although fruit/vegetable juices contain
bioactive compounds such as vitamins and phytochemicals, they
are stripped of the fiber once had in their whole food form and
have sugar and energy contents similar to SSB (60). Additionally,
liquid sources of sugar affect satiety differently than solid sources
(61). A distinction is made between different types of fruit juices;
sugar-sweetened fruit juice has been reported to increase the
risk of developing T2D in some prospective studies (55, 62),
while in others 100% fruit juice showed no association (63–65)
as confirmed by a meta-analysis (66). Sugar-sweetened fruit juice
was defined as an SSB in our study, and our juice variable came
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from fruit and vegetable sources; no associations were observed
for fruit juice intake in our study.
Our finding relating to the inverse association of urinary
fructose on insulin levels is in line with evidence from short-
term trials that reported decreases in circulating insulin in
subjects consuming fructose-sweetened beverages compared to
glucose-sweetened beverages (13, 14). Fructose consumption
causes smaller excursions in insulin due to its inability to
stimulate the secretion of insulin from pancreatic beta cells.
This was also confirmed by a meta-analysis of randomized
trials wherein iso-energetic replacements of glucose and sucrose
with fructose resulted in decreased insulin levels (56). On the
other hand, our finding that indicates a beneficial association
of fructose intake with insulin sensitivity was not confirmed
by many intervention studies in which high proportions of
fructose are consumed. These fructose over-consumption trials
almost consistently report that higher intakes of fructose lead
to decreases in insulin sensitivity (67–70). Many of the studies
outlining the biological pathways of fructose administer high
levels of pure fructose and the observed outcomes are not
applicable to the amount of fructose typically consumed by
humans, particularly considering that fructose is most often co-
ingested with glucose via sucrose or HFCS in ratios similar
to sucrose. The human diet rarely encounters fructose as a
single nutrient. When looking at the effects of small doses of
fructose, a meta-analysis reported that small fructose intakes
in iso-energetic exchange improves HbA1c and fasting blood
glucose but had no effect on insulin resistance (71). When
assessing the effect of dietary fructose, a distinction needs to be
made between trials that administer high vs. low doses. Of note,
our DONALD population consumed relatively low amounts of
fructose. Thus, the comparisons made between our findings
and those above are not helpful in explaining our results, also
because we investigated longer-term relevance which is different
from a short- or medium-term response to fructose consumption
(evidence from available randomized controlled trials) unless
a metabolic adaptation occurs during adolescence. Considering
adult dietary sugar intake in our population, it was unrelated to
both the outcomes and the predictors and thus did not change
the findings.
In considering why it was only among females that the
beneficial association of fructose was observed, other DONALD
studies also reported that females were more influenced by
dietary changes than men (72, 73). It has been reported that
women show more dramatic changes than men in hormones
and body composition due to reproductive factors, which may
cause them to react more sensitively to changes in dietary
influences. Differences between men and women are biology-
linked and caused by differences in sex chromosomes, hormones,
and gene expression of sex-specific autosomes, which can each
have effects on organ systems (74). Especially during adolescence
when the fuel economy shifts away from fatty acid composition
and ketogenesis toward carbohydrate oxidation, there is reduced
metabolic flexibility making puberty a vulnerable period for
changes in body composition (75). Women generally have
lowered insulin sensitivity (75–77) (as was also observed in this
present study) or increased impaired glucose tolerance than do
males (74), which may increase their susceptibility or sensitivity
to dietary influences.
Sugars are often among the nutrients that are frequently
misreported and perceived negatively because they are a source
of empty calories and are a common ingredient in unhealthy
foods (27, 28). A possible explanation in the present analysis for
the contrasting regression results between dietary fructose and
urinary fructose is selective underreporting of sugar-rich foods,
e.g., sugar sweetened beverages or sweets. There is to date no
reliable method to identify selective sugar underreporting. Our
sensitivity analyses excluding underreporters of energy intake,
i.e., dietary records that had implausible energy intake values,
yielded similar results. The use of urinary biomarkers to estimate
dietary sugar intake may produce more reliable results as they
are less subject to measurement and misreporting errors. The
inconsistency in the reported findings of observational studies
that investigate relations between sugar and disease outcomes
may be due to the ambiguity of the employed dietary assessment
methods. This being said, weighed dietary records as used
by the DONALD study have been considered to be the most
accurate dietary assessment tool for larger study populations,
and measurement errors using these records are smaller than
for other methods of assessment (78, 79). Evidence based on
self-reported intake, however, may be considered lower-grade
when compared to objective dietary biomarkers, especially due
to selective underreporting of unhealthy foods (80). Neither
fructose nor sucrose is endogenously synthesized, therefore
urinary excretion has to be of dietary origin. A small amount
of sucrose escapes from enzymatic hydrolysis in the small
intestine and enters into blood stream before becoming excreted.
For ingested fructose, a small proportion derived from free
fructose and from hydrolysis of sucrose escapes hepatic fructose
metabolism and is likewise excreted through the urine. In the
existing literature it is still debated which sugars (extrinsic,
intrinsic, total, added, free, etc.) are really captured by urinary
sucrose and fructose excretion (29, 30, 81, 82). In a previous
DONALD publication, it was found that dietary total sugar was
more strongly associated with excreted fructose than dietary
added sugar (83). While the relationship between intake and
excretion is more complex for 24 h urinary sugars than for
recovery biomarkers, they have been shown to reflect intake as
so-called predictive biomarkers. Following extensive validation
data, Tasevska et al. (84) have shown that it is possible to estimate
actual intake from these markers when one considers age and sex.
Both dietary and biomarker methods of assessment are analyzed
and compared in this study; they have different sources of error
and do not necessarily cover the exact same days of assessment
(rather the same overall time period).
The main strength of the present study was its longitudinal
design, including the long follow-up, which allowed the
investigation of the long-term associations between dietary sugar
intake in adolescence outcomes in young adulthood. Unlike
many other observational studies of this nature, it was a strength
that our study allowed comparisons of associations on the dietary
as well as the urinary level. The urinary biomarkers are less
subject to confounding by other nutrients or underreporting. In
addition, our continuously updated in-house nutrient database
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LEBTAB allowed the consideration of fructose, glucose and
sucrose as well as different types of fructose-containing sugars
(total sugar, free sugar, added sugar). Our study was able to
consider brand-specific sugar content in commercial products as
well as sugars or sweetening agents such as syrups and honey
which are used for food preparation at home. Furthermore, the
urine analyses were carried out in established laboratories by
scientists with years of experience in the measurement of sugar
excretion in 24 h-urine samples.
Our study was limited by the availability of only one blood
sample in young adulthood. It could be argued that the follow-
up time was rather short considering the younger age of the
cohort, and therefore endpoints of incidence could not be
assessed. Since T2D rates occur ever increasingly in younger
populations we justified the decision to measure risk factors
for T2D already in early adulthood. A further limitation in the
methods used was the handling of our urine samples, which
in contrast to previous studies (29, 30) were frozen without
preservatives for a long period of time (the earliest 24 h urine was
collected in 1985), which may have caused sucrose hydrolysis.
Such a possible hydrolysis of sucrose would, however, query
the successful application of urinary sucrose as a biomarker
in large epidemiological studies in which urine samples are
mostly stored without preservatives. Luceri et al. (58) were the
first to examine urinary biomarkers for sugar intake referring
only to the instability of sucrose in urine samples stored at
room temperature. Since our samples were stored at < −12◦C
during the collection period at home as well as at −22◦C in
the study institute, our samples remained frozen until use. The
generalizability of our results was limited due to the relatively
high SES of the DONALD study population and high SES
is known to correlate with lower dietary sugar intake (85).
Nevertheless, our sugar intake data were similar to sugar intake
in representative German nutrition survey (86, 87) as well as our
sugar excretion data, which were similar to sugar excretion in
other study populations (33, 88, 89).
In conclusion, these observational findings did not confirm
that dietary sugar consumption in adolescence is related to
insulin sensitivity in adulthood. The one potential exception to
this was dietary fructose (as measured by a urinary fructose
biomarker), which had a beneficial association with HOMA2-
S% and fasting insulin levels among females in the context of a
moderate fructose consumption pattern. No other associations
were found between the various dietary/urinary sugars and
insulin sensitivity or systemic inflammation.
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